{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:16:56Z","timestamp":1791649016600,"version":"4.3.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T00:00:00Z","timestamp":1565568000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T00:00:00Z","timestamp":1565568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s13346-019-00663-w","type":"journal-article","created":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T17:03:51Z","timestamp":1565629431000},"page":"70-82","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Classification of the crystallization tendency of active pharmaceutical ingredients (APIs) and nutraceuticals based on their nucleation and crystal growth behaviour in solution state"],"prefix":"10.1007","volume":"10","author":[{"given":"Sneha","family":"Rathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul B.","family":"Chavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5246-7935","authenticated-orcid":false,"given":"Nalini R.","family":"Shastri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,12]]},"reference":[{"issue":"8","key":"663_CR1","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.drudis.2017.01.010","volume":"22","author":"A Dalpiaz","year":"2017","unstructured":"Dalpiaz A, Pavan B, Ferretti V. Can pharmaceutical co-crystals provide an opportunity to modify the biological properties of drugs? Drug Discov Today. 2017;22(8):1134\u20138.","journal-title":"Drug Discov Today"},{"issue":"8","key":"663_CR2","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1002\/jps.21650","volume":"98","author":"J Brouwers","year":"2009","unstructured":"Brouwers J, Brewster ME, Augustijns P. Supersaturating drug delivery systems: The answer to solubility-limited oral bioavailability? J Pharm Sci. 2009;98(8):2549\u201372.","journal-title":"J Pharm Sci"},{"issue":"4","key":"663_CR3","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/jphp.12927","volume":"71","author":"Daniel J. Price","year":"2018","unstructured":"Price DJ, Ditzinger F, Koehl NJ, Jankovic S, Tsakiridou G, Nair A, Holm R, Kuentz M, Dressman JB, Saal C. Approaches to increase mechanistic understanding and aid in the selection of precipitation inhibitors for supersaturating formulations\u2013a PEARRL review. J Pharm Pharmacol. 2019;71(4):483\u2013509.","journal-title":"Journal of Pharmacy and Pharmacology"},{"issue":"1","key":"663_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0169-409X(01)00100-4","volume":"48","author":"KR Morris","year":"2001","unstructured":"Morris KR, et al. Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes. Adv Drug Deliv Rev. 2001;48(1):91\u2013114.","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"663_CR5","doi-asserted-by":"publisher","first-page":"5007","DOI":"10.1021\/cg1011633","volume":"10","author":"PG Vekilov","year":"2010","unstructured":"Vekilov PG. Nucleation. Cryst Growth Des. 2010;10(12):5007\u201319.","journal-title":"Cryst Growth Des"},{"issue":"2","key":"663_CR6","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1021\/cg301447d","volume":"13","author":"GA Ilevbare","year":"2012","unstructured":"Ilevbare GA, et al. Maintaining supersaturation in aqueous drug solutions: Impact of different polymers on induction times. Cryst Growth Des. 2012;13(2):740\u201351.","journal-title":"Cryst Growth Des"},{"key":"663_CR7","doi-asserted-by":"crossref","unstructured":"Mullin JW. Crystallization. 4th ed. Elsevier: Butterworth-Heinemann;2001.","DOI":"10.1016\/B978-075064833-2\/50009-7"},{"issue":"5","key":"663_CR8","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1002\/jps.23498","volume":"102","author":"DD Patel","year":"2013","unstructured":"Patel DD, Anderson BD. Maintenance of supersaturation II: indomethacin crystal growth kinetics versus degree of supersaturation. J Pharm Sci. 2013;102(5):1544\u201353.","journal-title":"J Pharm Sci"},{"key":"663_CR9","volume-title":"Encyclopedia of Pharmaceutical Technology: Volume 20-Supplement 3","author":"J Swarbrick","year":"2000","unstructured":"Swarbrick J, Boylan JC. Encyclopedia of Pharmaceutical Technology: Volume 20-Supplement 3. 3rd ed. Florida: CRC Press; 2000.","edition":"3"},{"issue":"9","key":"663_CR10","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1002\/jps.23890","volume":"103","author":"YL Hsieh","year":"2014","unstructured":"Hsieh YL, Box K, Taylor LS. Assessing the Impact of Polymers on the pH-Induced Precipitation Behavior of Poorly Water Soluble Compounds using Synchrotron Wide Angle X-Ray Scattering. J Pharm Sci. 2014;103(9):2724\u201335.","journal-title":"J Pharm Sci"},{"issue":"81","key":"663_CR11","doi-asserted-by":"publisher","first-page":"77569","DOI":"10.1039\/C6RA19746A","volume":"6","author":"RB Chavan","year":"2016","unstructured":"Chavan RB, et al. Evaluation of the inhibitory potential of HPMC, PVP and HPC polymers on nucleation and crystal growth. RSC Adv. 2016;6(81):77569\u201376.","journal-title":"RSC Adv"},{"issue":"9","key":"663_CR12","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1021\/mp500201s","volume":"11","author":"MJ Jackson","year":"2014","unstructured":"Jackson MJ, et al. Impact of polymers on the precipitation behavior of highly supersaturated aqueous danazol solutions. Mol Pharm. 2014;11(9):3027\u201338.","journal-title":"Mol Pharm"},{"issue":"2","key":"663_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/pharmaceutics8020017","volume":"8","author":"M Li","year":"2016","unstructured":"Li M, et al. Nanomilling of drugs for bioavailability enhancement: a holistic formulation-process perspective. Pharmaceutics. 2016;8(2):17.","journal-title":"Pharmaceutics"},{"issue":"3","key":"663_CR14","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1021\/la0523661","volume":"22","author":"L Lindfors","year":"2006","unstructured":"Lindfors L, et al. Amorphous drug nanosuspensions. 1. Inhibition of Ostwald ripening. Langmuir. 2006;22(3):906\u201310.","journal-title":"Langmuir"},{"issue":"12","key":"663_CR15","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1039\/C2CE26490K","volume":"15","author":"KA Oucherif","year":"2013","unstructured":"Oucherif KA, et al. Quantitative analysis of the inhibitory effect of HPMC on felodipine crystallization kinetics using population balance modeling. CrystEngComm. 2013;15(12):2197\u2013205.","journal-title":"CrystEngComm"},{"issue":"6","key":"663_CR16","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.addr.2011.02.001","volume":"63","author":"L Wu","year":"2011","unstructured":"Wu L, Zhang J, Watanabe W. Physical and chemical stability of drug nanoparticles. Adv Drug Deliv Rev. 2011;63(6):456\u201369.","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"663_CR17","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1002\/jps.22197","volume":"99","author":"JA Baird","year":"2010","unstructured":"Baird JA, Van Eerdenbrugh B, Taylor LS. A classification system to assess the crystallization tendency of organic molecules from undercooled melts. J Pharm Sci. 2010;99(9):3787\u2013806.","journal-title":"J Pharm Sci"},{"issue":"33","key":"663_CR18","doi-asserted-by":"publisher","first-page":"9974","DOI":"10.1021\/jp504450h","volume":"118","author":"NS Trasi","year":"2014","unstructured":"Trasi NS, et al. Factors influencing crystal growth rates from undercooled liquids of pharmaceutical compounds. J Phys Chem B. 2014;118(33):9974\u201382.","journal-title":"J Phys Chem B"},{"issue":"9","key":"663_CR19","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1002\/jps.22214","volume":"99","author":"B Van Eerdenbrugh","year":"2010","unstructured":"Van Eerdenbrugh B, Baird JA, Taylor LS. Crystallization tendency of active pharmaceutical ingredients following rapid solvent evaporation\u2014classification and comparison with crystallization tendency from under cooled melts. J Pharm Sci. 2010;99(9):3826\u201338.","journal-title":"J Pharm Sci"},{"issue":"4","key":"663_CR20","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s11095-013-1216-z","volume":"31","author":"B Van Eerdenbrugh","year":"2014","unstructured":"Van Eerdenbrugh B, et al. Classification of the crystallization behavior of amorphous active pharmaceutical ingredients in aqueous environments. Pharm Res. 2014;31(4):969\u201382.","journal-title":"Pharm Res"},{"issue":"9","key":"663_CR21","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1021\/acs.molpharmaceut.6b00650","volume":"13","author":"LI Blaabjerg","year":"2016","unstructured":"Blaabjerg LI, et al. Glass forming ability of amorphous drugs investigated by continuous cooling and isothermal transformation. Mol Pharm. 2016;13(9):3318\u201325.","journal-title":"Mol Pharm"},{"issue":"6","key":"663_CR22","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/jps.20613","volume":"95","author":"KJ Box","year":"2006","unstructured":"Box KJ, et al. Equilibrium versus kinetic measurements of aqueous solubility, and the ability of compounds to supersaturate in solution\u2014a validation study. J Pharm Sci. 2006;95(6):1298\u2013307.","journal-title":"J Pharm Sci"},{"issue":"20","key":"663_CR23","doi-asserted-by":"publisher","first-page":"6503","DOI":"10.1039\/c2ce25515d","volume":"14","author":"GA Ilevbare","year":"2012","unstructured":"Ilevbare GA, et al. Inhibition of solution crystal growth of ritonavir by cellulose polymers\u2013factors influencing polymer effectiveness. CrystEngComm. 2012;14(20):6503\u201314.","journal-title":"CrystEngComm"},{"issue":"3","key":"663_CR24","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1021\/acs.molpharmaceut.5b00798","volume":"13","author":"T Xie","year":"2016","unstructured":"Xie T, Taylor LS. Improved release of celecoxib from high drug loading amorphous solid dispersions formulated with polyacrylic acid and cellulose derivatives. Mol Pharm. 2016;13(3):873\u201384.","journal-title":"Mol Pharm"},{"issue":"14","key":"663_CR25","doi-asserted-by":"publisher","first-page":"3344","DOI":"10.1016\/j.ces.2009.04.016","volume":"64","author":"LL Simon","year":"2009","unstructured":"Simon LL, Nagy ZK, Hungerbuhler K. Comparison of external bulk video imaging with focused beam reflectance measurement and ultra-violet visible spectroscopy for metastable zone identification in food and pharmaceutical crystallization processes. Chem Eng Sci. 2009;64(14):3344\u201351.","journal-title":"Chem Eng Sci"},{"issue":"11","key":"663_CR26","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.1002\/jps.22154","volume":"99","author":"J Bevernage","year":"2010","unstructured":"Bevernage J, et al. Drug Supersaturation in Simulated Human Intestinal Fluids Representing Different Nutritional States. J Pharm Sci. 2010;99(11):4525\u201334.","journal-title":"J Pharm Sci"},{"issue":"1","key":"663_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ijpharm.2012.11.026","volume":"453","author":"J Bevernage","year":"2013","unstructured":"Bevernage J, et al. Evaluation of gastrointestinal drug supersaturation and precipitation: strategies and issues. Int J Pharm. 2013;453(1):25\u201335.","journal-title":"Int J Pharm"},{"issue":"3","key":"663_CR28","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/17425247.2016.1218465","volume":"14","author":"SYK Fong","year":"2017","unstructured":"Fong SYK, Bauer-Brandl A, Brandl M. Oral bioavailability enhancement through supersaturation: an update and meta-analysis. Expert Opin Drug Deliv. 2017;14(3):403\u201326.","journal-title":"Expert Opin Drug Deliv"},{"issue":"9","key":"663_CR29","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1016\/j.jcrysgro.2009.02.027","volume":"311","author":"E Abdel-Aal","year":"2009","unstructured":"Abdel-Aal E, Daosukho S, El-Shall H. Effect of supersaturation ratio and Khella extract on nucleation and morphology of kidney stones. J Cryst Growth. 2009;311(9):2673\u201381.","journal-title":"J Cryst Growth"},{"issue":"2","key":"663_CR30","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1021\/cg0602212","volume":"7","author":"A Kuldipkumar","year":"2007","unstructured":"Kuldipkumar A, Kwon GS, Zhang GG. Determining the growth mechanism of tolazamide by induction time measurement. Cryst Growth Des. 2007;7(2):234\u201342.","journal-title":"Cryst Growth Des"},{"issue":"8","key":"663_CR31","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1021\/mp300576u","volume":"10","author":"DB Warren","year":"2013","unstructured":"Warren DB, et al. Evaluation of the structural determinants of polymeric precipitation inhibitors using solvent shift methods and principle component analysis. Mol Pharm. 2013;10(8):2823\u201348.","journal-title":"Mol Pharm"},{"issue":"8B","key":"663_CR32","doi-asserted-by":"publisher","first-page":"B90","DOI":"10.1088\/0022-3727\/26\/8B\/013","volume":"26","author":"S Khoshkhoo","year":"1993","unstructured":"Khoshkhoo S, Anwar J. Crystallization of polymorphs: the effect of solvent. J Phys D Appl Phys. 1993;26(8B):B90.","journal-title":"J Phys D Appl Phys"},{"key":"663_CR33","doi-asserted-by":"publisher","DOI":"10.1201\/9780203908280","volume-title":"Crystallization technology handbook","author":"A Mersmann","year":"2001","unstructured":"Mersmann A. Crystallization technology handbook. 2nd ed. Florida: CRC Press; 2001.","edition":"2"},{"issue":"3","key":"663_CR34","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1021\/cg201590j","volume":"12","author":"DE Alonzo","year":"2012","unstructured":"Alonzo DE, et al. Characterizing the impact of hydroxypropylmethyl cellulose on the growth and nucleation kinetics of felodipine from supersaturated solutions. Cryst Growth Des. 2012;12(3):1538\u201347.","journal-title":"Cryst Growth Des"},{"issue":"7","key":"663_CR35","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1002\/jps.22478","volume":"100","author":"DD Patel","year":"2011","unstructured":"Patel DD, et al. Maintenance of supersaturation I: Indomethacin crystal growth kinetic modeling using an online second-derivative ultraviolet spectroscopic method. J Pharm Sci. 2011;100(7):2623\u201341.","journal-title":"J Pharm Sci"},{"issue":"5","key":"663_CR36","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1007\/s11095-016-1871-y","volume":"33","author":"MJ Jackson","year":"2016","unstructured":"Jackson MJ, et al. Characterization of supersaturated danazol solutions\u2013Impact of polymers on solution properties and phase transitions. Pharm Res. 2016;33(5):1276\u201388.","journal-title":"Pharm Res"},{"issue":"1","key":"663_CR37","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/jps.22760","volume":"101","author":"S Ozaki","year":"2012","unstructured":"Ozaki S, et al. Supersaturation\u2013nucleation behavior of poorly soluble drugs and its impact on the oral absorption of drugs in thermodynamically high-energy forms. J Pharm Sci. 2012;101(1):214\u201322.","journal-title":"J Pharm Sci"},{"issue":"10","key":"663_CR38","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1007\/s11095-015-1709-z","volume":"32","author":"LA Wegiel","year":"2015","unstructured":"Wegiel LA, et al. Phase behavior of resveratrol solid dispersions upon addition to aqueous media. Pharm Res. 2015;32(10):3324\u201337.","journal-title":"Pharm Res"},{"issue":"1","key":"663_CR39","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ijpharm.2017.08.099","volume":"531","author":"T Xie","year":"2017","unstructured":"Xie T, Gao W, Taylor LS. Impact of Eudragit EPO and hydroxypropyl methylcellulose on drug release rate, supersaturation, precipitation outcome and redissolution rate of indomethacin amorphous solid dispersions. Int J Pharm. 2017;531(1):313\u201323.","journal-title":"Int J Pharm"},{"key":"663_CR40","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1016\/S0022-0248(01)02284-9","volume":"237","author":"J Ulrich","year":"2002","unstructured":"Ulrich J, Strege C. Some aspects of the importance of metastable zone width and nucleation in industrial crystallizers. J Cryst Growth. 2002;237:2130\u20135.","journal-title":"J Cryst Growth"},{"issue":"9","key":"663_CR41","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/nrd1494","volume":"3","author":"BE Rabinow","year":"2004","unstructured":"Rabinow BE. Nanosuspensions in drug delivery. Nat Rev Drug Discov. 2004;3(9):785.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"663_CR42","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.tifs.2015.07.005","volume":"46","author":"GH Shin","year":"2015","unstructured":"Shin GH, Kim JT, Park HJ. Recent developments in nanoformulations of lipophilic functional foods. Trends Food Sci Technol. 2015;46(1):144\u201357.","journal-title":"Trends Food Sci Technol"},{"issue":"3","key":"663_CR43","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ejpb.2013.10.005","volume":"86","author":"AL Sarode","year":"2014","unstructured":"Sarode AL, et al. Supersaturation, nucleation, and crystal growth during single-and biphasic dissolution of amorphous solid dispersions: Polymer effects and implications for oral bioavailability enhancement of poorly water soluble drugs. Eur J Pharm Biopharm. 2014;86(3):351\u201360.","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"663_CR44","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.ejpb.2008.05.023","volume":"70","author":"H Konno","year":"2008","unstructured":"Konno H, et al. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine. Eur J Pharm Biopharm. 2008;70(2):493\u20139.","journal-title":"Eur J Pharm Biopharm"},{"issue":"9","key":"663_CR45","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1021\/cg200352u","volume":"11","author":"T Vetter","year":"2011","unstructured":"Vetter T, Mazzotti M, Brozio J. Slowing the growth rate of ibuprofen crystals using the polymeric additive Pluronic F127. Cryst Growth Des. 2011;11(9):3813\u201321.","journal-title":"Cryst Growth Des"},{"issue":"6","key":"663_CR46","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1002\/jps.24423","volume":"104","author":"SA Raina","year":"2015","unstructured":"Raina SA, et al. Trends in the precipitation and crystallization behavior of supersaturated aqueous solutions of poorly water-soluble drugs assessed using synchrotron radiation. J Pharm Sci. 2015;104(6):1981\u201392.","journal-title":"J Pharm Sci"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-019-00663-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13346-019-00663-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-019-00663-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T23:30:31Z","timestamp":1597102231000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13346-019-00663-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,12]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["663"],"URL":"https:\/\/doi.org\/10.1007\/s13346-019-00663-w","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,12]]},"assertion":[{"value":"12 August 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}